Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Honest question is the O/S really aprrox 1,380,000,000? Thats what I got out of the website and the T/A wont give #'s and RB is stating different #'s. Just trying to get a feel before I purchase.
IMNR>>>BLUE SKIES MOMO!!!!!!!!!!!!!!!!!!!!!!!
IMNR HOD!!!!!!!!!!!!!!!!!!!
Excellent! I'm in @.023 eom
Besides when do you EVER see me play your picks very very rare...insider buying at .02 they want this stock price up. imo
With everything I read on IMNR...and my charts .024 and .025 are tough but watch this afternoon
imnr im drowning > i thought thiz was gonna be larger than lolliezzz arzzzzzzz > my new id = shakerclownzzz lmfaoooooooooooooooo
lmfaooooooooooooooo
i guess we gotta wait till Lolly finishes her corn the long way.
IMNR up we go from here imo
wtf i got over 10 mill now lol
i think we need lolly to help us on this one...lol.she has big pockets from her profits from BCIT.
wtffffffffffffffffffffffffffffffffffff is wrong with this ??
IMNR bottom of channel here imo
might get a little dip then kaboom! LOL!
stubborn feker wtfffffffffffffffffffffffff
IMNR >>> NOT MUCH LEFT UNDER .03 <> MM OLMP NEEDS TO BE DESTROYED >> 52 RANGE .02 TO .85 GOOOOOOOOOOO IMNR
IMNR >>> NOT MUCH LEFT UNDER .03 <> MM OLMP NEEDS TO BE DESTROYED >> 52 RANGE .02 TO .85 GOOOOOOOOOOO IMNR
WEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEE
HAHAHAH good lookin out. THANKS :)
maybe more >> gl and nice sig weeeeeeeeeeeeeeee
IMNR ~ SHAKERZZZZZ ~ 3 DAY TOUR ???
How long is this bus ride gonna last?
IMNR>> •(52 range .02 to .85) plus cornell = 1 hellava run starting (JMHO) The Company has several important clinical milestones in the coming year which we believe could drive the stock higher. We believe its current valuation understates the company’s value and earnings power. We see a valuation gap with other comparable companies.
Financial Highlights
Valuation Metrics
Other Investment Metrics
Market Capitalization
$ 13.1 mn
52-week range
$0.02-$0.85
Shares Outstanding
Approx. 656.5 mn
Avg. Trading Vol.
8.2 million
I saw the two year chart and noticed cornell capital loaned them a million dollars back in aug 4, 2005 and crashed the stock
it is going to be a gazelle now >>> 1 year anniversary but from bottom to top > this chart is perfect for the newbies to divr in head first > jmho > MAY TAKE FEW WEEKS TO GET BACK ON TOP BUT IM LUVING INSIDER BUYING AND RECENT PHASE 2 EXPANSION ON HIV
AGREED > BUT LETS GET .08 BRO
Insider buying is misleading...
I see a lot of people making assumptions based on the insider buying. If you dig deeper you will see a stock match plan went into effect on the 15th of June and the insider buying started on the 20th of June. This means for every share they buy they get a free one.
Is it possible for them to buy 50k worth of shares at .02, hype the new treatments in development and get the price up to .04 and then sell all shares and get 200k back? You bet! Is it also possible for the new treatments to be great and the price rise to 1.00, sure. Which is more likely thou???
Dont buy based on insider buying on this one is all I'm saying.
Thought that I would come on over here and see what's going on.
E-trade not letting me put in limit sell order. What gives?
link does not work kewl
IMNR Huge news. Look Big guys on Nasdaq checking INMR out, it's on marketwatch.com, List with Nasday stocks that trade for 17 dollars to 100 dollars!
IMNR going to be HUGE! Also SLJB big play too...
Here's the link...
http://www.marketwatch.com/News/Story/Story.aspx?guid=%7B1AC0D5EF%2DCDA3%2D4224%2DB4EC%2DC76DAE27CED....
no problem! looking good fresno!
THANKS MOMO, WE NEED THIS. CUDOS!!!!!!!!!!!!!!GO IMNR!!!!!
HOPING TOMORROW WILL BE GREAT!!!!!!!
News: The Immune Response Corporation Receives Approval for Expansion of Phase II Trial in France for Investigative HIV Immunotherapy IR103.
could bring some activity, bottom there, time to leave
Stockguru.com: Morning Updates for Thursday, July 27, 2006 Featuring The Immune Response Corporation, 110 Media Group, and Coil Tubing Technology
Dallas, Texas, Jul 27, 2006 (M2 PRESSWIRE via COMTEX) -- StockGuru Pre-Market Updates for Thursday include The Immune Response Corporation (OTCBB: IMNR), 110 Media Group, Inc. (OTCBB: ONTN), and Coil Tubing Technology, Inc. (OTC: CTBG). StockGuru Pre-Market Updates feature companies with significant moves in either volume or price in the past two trading sessions. In our update we analyze recent news about the companies featured and detail the movement in the stock. If you would like to feature your publicly traded company in our alerts or on StockGuru.com, email feature@stockguru.com or call (469)252-3031.
The Immune Response Corporation (OTCBB: IMNR) - Wednesday's shares closed down 3.11% to $0.0218. 5,245,489 shares were traded. The Immune Response Corporation announced on July 24th that IncreMental Advantage, an equity research firm, initiated coverage on the Company with an Accumulate rating, and a price target of $0.09 per share. The Immune Response Corporation's product pipeline has two clinical stage therapeutics in Phase II development, NeuroVax(TM) for multiple sclerosis (MS), and IR103 for HIV/AIDS. The report was issued by IncreMental's highly experienced biotechnology analyst, Robert LeBoyer, who has more than 14 years of Wall Street experience. IncreMental Advantage noted in the report that, "The current market capitalization is only $13.1 million. It is unusual to find such a company with two novel products in Phase II clinical trials."
The Immune Response Corporation is an immuno-pharmaceutical company focused on developing products to treat autoimmune and infectious diseases. The Company's lead immune-based therapeutic product candidates are NeuroVax for the treatment of MS and IR103 for the treatment of HIV infection. Both of these therapies are in Phase II clinical development and are designed to stimulate pathogen-specific immune responses aimed at slowing or halting the rate of disease progression.
For a quote and the latest news on this company, please visit: http://www.stockguru.com/profiles/imnr.php .
110 Media Group, Inc. (OTCBB: ONTN) - Wednesday's shares stayed even at $1.15. The volume was 2,500. 110 Media Group announced on July 10th that it is changing its name to Web2 Corp. in order to more closely align its identity with the strategic direction of the company. Approved by the Board of Directors and a majority of shareholders, the new identity as Web2 Corp. signals a new focus on development of innovative Internet products targeting E-commerce, small businesses and next-generation online tools. The process of completing the name change is expected to be completed before the end of July. The company now trades on the OTC:BB Electronic Quotation Service under the trading symbol "ONTN," but expects to obtain a new symbol upon completion of the name change.
110 Media Group, Inc. offers products and services that address a significant market gap by providing non-technical business operators of small to medium-sized businesses with all the necessary services needed to migrate their cottage industries to the Internet or to start a new Internet business. 110 Media's Chamber of eCommerce packages provide all the necessary components for a successful online business in just one hour. The Company's integrated friendly, helpful, non-threatening bundle can be easily accessed and managed by low-tech business operators. The company profitably provides all elements basic to any business endeavor in a cost-effective package offered for $19.95 per month with no start-up fees. Clients simply need to add their information and products or services to be in business in as little as an hour without knowing a thing about HTML, Flash, Secure Socket Layers, FTP, or any other technical aspect of creating and running a website.
For a quote and the latest news on this company, please visit: http://www.stockguru.com/profiles/ontn.php .
Coil Tubing Technology, Inc. (OTC: CTBG) - Wednesday's shares increased 5.26% to $0.10. 50,600 was the volume. Coil Tubing Technology announced on May 25th the delivery of the first group of eight (8) two-and-seven-eighths-inch (2 7/8") Rotating Tools to oil and gas well service companies operating in Mexico and Oklahoma. Designed for use in "fishing" applications utilizing 2" coiled tubing strings, these tools were delivered and "in the field" the week of May 1, 2006. In addition, CTT has received orders for ten (10) more of these 2 7/8" Rotating Tool units, plus five (5) 2 1/8" Rotating Tools, all of which are scheduled for delivery to customers before the end of the month of May.
Coil Tubing Technology, Inc. (OTC: CTBG) has specialized in the design of proprietary tools for the coil tubing industry since 1990, concentrating on four categories of coil tubing application: thru tubing fishing, thru tubing work over, pipeline clean out, and coil tubing drilling. CTT was founded in 1998 by Jerry Swinford, an oilfield tool designer with more than 15 patents granted or pending and more than 25 years experience in the creation of oilfield tools. To maximize service worldwide, CTT, associated with the German company Hammelmann (a major provider of high pressure pumping systems and nozzle systems), have joined forces to develop and introduce to the coiled tubing industry the "RotorJet Nozzle System" (for down hole tubular cleanout) and advance the CTT market utilizing Hammelmann's extensive distribution network worldwide. The "CTT / Hammelmann Rotorjet Nozzle" is capable of removing barium, calcium carbonate, cement, tars, filter cake and iron sulfides from well bores.
For a quote and the latest news on this company, please visit: http://www.stockguru.com/profiles/ctbg.php .
About StockGuru.com:
StockGuru.com features daily alerts going out three times daily to members. To join our email alert list, please visit: http://www.stockguru.com/stocks.htm .
To feature your publicly traded company in our alerts, or to discuss our complete services, please contact: John Pentony at (469) 252-3031. Our services include our StockGuru Pre-Market Alerts, StockGuru Volume Alerts, StockGuru Price Alerts, StockGuru Midday Alerts, and StockGuru After The Bell. Additionally we Profile publicly traded companies on our web site, we do interviews with CEO's or other key executives on our web site, and we have our financial writers cover our companies.
Those interested may also email: feature@stockguru.com or call (469) 252-3031 and we will gladly send more information on featuring your company with StockGuru.com.
Stockguru.com ("SG") provides its members with the latest news, press releases, and research reports for all the companies highlighted on the site. SG utilizes information believed to be reliable herein prepared all material. The information contained herein is not guaranteed by SG to be accurate, and should not be considered to be all-inclusive. The owner, publisher, editor and their associates are not responsible for errors and omissions. They may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. SG encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and SG makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies or the information contained herein. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SG is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on http://www.Stockguru.com or mentioned herein.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies= annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SG undertakes no obligation to update such statements.
IMNR Disclosure: Pentony Enterprises LLC was compensated $17,500 from ROI Group Associates Inc. for profile coverage. ONTN Disclosure: Pentony Enterprises LLC is expected to be compensated up to $16,000 for profile coverage. CTBG Disclosure: Pentony Enterprises LLC was compensated $20,000 by a non-controlling third-party for profile coverage. Pentony Enterprises LLC is not a registered investment advisers or broker/dealers. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.
CONTACT: John Pentony, Publisher Tel: +1 469 252 3031 e-mail: feature@stockguru.com
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
(C)1994-2006 M2 COMMUNICATIONS LTD
-0-
Bell2Bell.com: Aggressive Stock Trader Alert: MTNA, IMNR, CYOS
SARASOTA, Fla., Jul 26, 2006 (M2 PRESSWIRE via COMTEX) -- Stocks to watch for today are - Material Technologies, Inc. (OTCBB: MTNA), The Immune Response Corporation (OTCBB: IMNR), CYOP Systems International Inc. (OTCBB: CYOS):
Investors, continue to follow Material Technologies, Inc. (OTCBB: MTNA), a company engaged in the research and development of metal fatigue detection, measurement and monitoring technologies. After the bell Tuesday the company announced that it has identified significant need and wide potential application in the aviation industry for its patented metal fatigue detection technology.
Material Technologies said that its innovative Fatigue Fuse(TM), the company's patented advanced testing device, can be used by aircraft manufacturers, commercial airlines, general aviation companies and maintenance, repair and overhaul providers to track the accumulation of metal fatigue in aircraft structures over time.
The Fatigue Fuse can be attached to a structural member to count severe load cycles, gauge fatigue damage and estimate the remaining life of the structure, the company explained, and said that by applying the Fatigue Fuse to aircraft components aviation engineers can improve maintenance, repair and overhaul efforts, make better decisions based on accurate load information, prevent catastrophic structural failure, and ensure the safety of passengers and cargo.
Robert M. Bernstein, CEO of Material Technologies, Inc. (OTCBB: MTNA) commented, "More than 90% of all structural cracks in aircraft involve fatigue. Our groundbreaking Fatigue Fuse technology can count severe load cycles and measure their cumulative effects to predict how long an aircraft's wing or tail will retain its structural integrity."
Bernstein said that the Fatigue Fuse had been tested by a leading British commercial and military aircraft manufacturer with excellent results, and added, "We believe our advanced nondestructive metal fatigue detection solutions are a perfect fit for the aviation industry and we are initiating a campaign to capitalize on the tremendous opportunity we have identified."
Material Technologies, Inc. (OTCBB: MTNA) is currently trading at around 6 cents a share.
Other stocks to watch:
The Immune Response Corporation (OTCBB: IMNR) announced Tuesday that equity research firm, IncreMental Advantage, had initiated coverage on the company with an Accumulate rating and a price target of 9 cents per share.
IMNR closed Tuesday at $0.0225.
RedFelt Software Ltd., a subsidiary of CYOP Systems International Inc. (OTCBB: CYOS), announced Tuesday that the company had started marketing its website RedFeltPoker.com to Affiliates, through a new site is called RedFeltGold.com.
CYOS closed Tuesday at $0.0165.
About eLocity Inc: eLocity owns and operates three financial websites for investors.
-PennyPicks.com, http://www.pennypicks.com/. Featuring active message boards for the penny stock trader, rumors and more.
-StockGrid.com, http://www.stockgrid.com/. Visit this site for our daily top stock "GRID Makers". We rank stocks on volume, message board activity, sentiment and trend forecast.
-Bell2Bell.com, http://www.bell2bell.com/. Bell2Bell features news stories, rumors, the InvestBoard and more.
Sign up for FREE at any of the sites above.
Contact: eLocity Inc.
941-544-3498
The newsletter is provided by eLocity Inc., an electronic broadcaster and publisher of this newsletter, is here after referred to as "the company". The company received compensation for this service for MTNA (Public Company). The compensation is one thousand, two hundred dollars from a non-affiliated third party, Equity Alliance, Inc. Because the company received compensation for its services, there is an inherent conflict of interest in the company statements and opinions and such statements and opinions cannot be considered independent.
The company reserves the right to trade in securities mentioned herein, and may make purchases or sales in such securities featured within our newsletter reports. The information contained in this publication is for informational purposes only, and not to be construed as an offer to sell or solicitation of an offer to buy any security. The company makes no representation or warranty relating to the validity of the facts presented nor does the company represent or warrant that all material facts necessary to make an investment decision are presented above. All statements of opinions, if any, (Our Summary) are those of the company.
The company relies exclusively on information gathered on the Public Company, such as public filings, press releases and its web sites. Investors should use the information contained in this publication as a starting point for conducting additional research on the Public Company in order to allow the investor to form his or her own opinion regarding the Public Company. Factual statements contained in this publication are made as of the date stated and they are subject to change without notice. The company is not a registered investment adviser, broker or a dealer.
Investing in the Public Company that this newsletter is providing service for should be reviewed is speculative and a high-risk and may result in the loss of some or all of any investment made in the client. This release may contain statements that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended.
The words "may," "would," "will," "expect," "estimate," "anticipate," "believe," "intend," and similar expressions and variations thereof are intended to identify forward-looking statements.
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
(C)1994-2006 M2 COMMUNICATIONS LTD
-0-
Search for Dun & Bradstreet reports on this company.
This much volume with no price increase = dilution. And dilution continues through August it appears. There is some good action over at PAIM
Dr. Joseph O’Neill comes to The Immune Response Corporation after leading federal AIDS policy at the White House; the Office of the U.S. Secretary of Health and Human Services; and, the Office of the Global AIDS Coordinator at the U.S. Department of State. These positions, which were instrumental in formulating AIDS policy, have given him extensive experience and knowledge of the HIV/AIDS epidemic, its treatments, and the challenges for future treatments. Dr. O’Neill brings important relationships with drug development sponsors and researchers, as well as valuable experience managing staffs of over 200 in locations around the world.
Thanks for the info sublime.
Overview In March 2006, the Company completed an $8.0 million convertible note offering. The offering included 1.2 billion warrants at $0.02 per share that were intended to bring additional cash later in 2006. These warrants have a short-term, and have an exercise value of roughly $24 million.
The first traunche of warrants is exercisable until August 7, 2006. When exercised, these warrants can bring up to $12 million to the Company. At this point, approximately 333.6 million warrants have been exercised, bringing $6.7 million to the company out of the potential $12 million in proceeds into the Company. We forecast that the remaining 266.4 million warrants scheduled to expire on August 7, 2006 will be exercised.
The second traunche of 600 million warrants becomes exercisable on October 16 and expire November 30, 2006. When exercised, these warrants will also bring up to $12 million to the Company.
Potential Dilution The Company had 656.5 million shares outstanding as of July 2006. If all warrants from the offering are exercised, the shares outstanding could increase to 1.525 billion. If all outstanding convertible debt and warrants were exercised, the shares outstanding would number approximately 2.7 billion.
Investors should note that the Company’s shareholders authorized a reverse split at an exchange ratio of up to 1:100. This would be aimed at increasing the market price and reducing the number of shares outstanding.
what do you believe its possible for the pps?
Dr. Jonas Salk founded this company??
The Company’s HIV/AIDS products are based on its patented whole-inactivated viral antigen technology developed by Company founder Dr. Jonas Salk. The mechanism of action is to replenish and stimulate the patient’s immune system to fight the infection. IR103 is a more potent, second generation product. This product is being developed to enhance the immune system’s ability to fight the HIV virus and extend the time before anti-retroviral therapies are needed.
Robert LeBoyer Senior Biotechnology Analyst
Robert LeBoyer has been following the Biotechnology Industry for over 12 years. He started in 1992 at Prudential Securities, and then moved to Brown Brothers Harriman. In 2000-01, he was Senior Biotechnology Analyst with Leerink Swann & Company.
Before joining EKN, Mr. LeBoyer was Director of Research and Senior Biotechnology Analyst at Diversified Biotechnology Group/InvestBio.
Mr. LeBoyer has followed drug development in many therapeutic fields, including cancer, neurology, infectious disease, dermatology, and drug delivery. He has frequently attended FDA Advisory Panel hearings, and covered patent lawsuits between drug development companies. Mr. LeBoyer's universe of coverage spans all market capitalization ranges, from the largest first tier companies to the development stage micro-cap companies. He has been part of numerous offerings and private placements as an underwriter and syndicate member.
Mr LeBoyer graduated from Tulane University with a BS in Economics and holds and MBS from Columbia Business School.
Followers
|
4
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
236
|
Created
|
08/17/03
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |